Skip to content
Trial Eligibility
Menu

SeeMe: Using Automated Facial Tracking to Detect Voluntary Behavior in Brain Injury

NCT07560631

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Objective: This prospective interventional study introduces "SeeMe," an automated, high-resolution computer vision platform designed to objectively quantify microscopic, auditory command-evoked movements in patients with Traumatic Brain Injury (TBI). Current clinical assessments, such as the Glasgow Coma Scale (GCS) and Coma Recovery Scale-Revised (CRS-R), rely on subjective human observation and often fail to detect low-amplitude motor responses, potentially misclassifying up to 25% of patients as unresponsive.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Traumatic Brain Injury (TBI) Patients
  • Severe Traumatic Brain Injury

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
22 to 85 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Stony Brook University
Last updated on ClinicalTrials.gov
May 5, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New York · 1

  • Stony Brook University Hospital · Stony Brook, NY

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.